Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Stage IB Uterine Corpus Cancer: later-stage trial registry

1 of 1 indexed Stage IB Uterine Corpus Cancer trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Stage IB Uterine Corpus Cancer: 1 US clinical trial tracked, 1 recruiting.

Stage IB Uterine Corpus Cancer is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Utah, running 1 of these trials.

Enrollment posture brief

Registry condition stage-ib-uterine-corpus-cancer

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Stage IB Uterine Corpus (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Stage IB Uterine Corpus Cancer

Stage IB Uterine Corpus Cancer lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Stage IB Uterine Corpus Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Stage IB Uterine Corpus Cancer is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Named interventions

Most-linked intervention names on Stage IB Uterine Corpus Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Short course vaginal cuff brachytherapy Radiation
1 trials
Vaginal Cuff Brachytherapy Radiation
1 trials

US sites by state

Facility locations filed on Stage IB Uterine Corpus Cancer trials. A trial with sites in several states counts in each.

Utah 1 trials
Texas 1 trials
Illinois 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Stage IB Uterine Corpus Cancer page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Stage IB Uterine Corpus Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Utah sponsors the most Stage IB Uterine Corpus Cancer trials on record, review their full trial history before evaluating a specific study. See University of Utah's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stage IB Uterine Corpus Cancer condition card totals 1 registered trials; most-linked intervention Short course vaginal cuff brachytherapy; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.